AI assistant
Ambu Major Shareholding Notification 2017
3353_rns_2017-11-21_18114e01-172a-4429-958d-2d3b33dc676a.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Ambu*
Ideas that work for life
Major Shareholder Announcement
In pursuance of §29 of the Danish Securities Trading Act (Værdipapirhandelsloven), Ambu A/S hereby reports that we have been informed by N. P. Louis-Hansen Aps that N. P. Louis-Hansen Aps' shareholdings in Ambu have been reduced from 15.2% to 14.9% of the share capital. The voting rights of 6.7% remain unchanged.
Contact
Lars Marcher, President & CEO, tel. +45 5136 2490, email: [email protected]
Ambu A/S
Baltorpbakken 13
DK-2750 Ballerup
Tel. +45 7225 2000
CVR no.: 63 64 49 19
www.ambu.com
About Ambu
Since 1937, breakthrough ideas have fuelled our work on bringing efficient healthcare solutions to life. This is what we create within our fields of excellence – Anaesthesia, Patient Monitoring & Diagnostics, and Emergency Care. Millions of patients and healthcare professionals worldwide depend on the functionality and performance of our products. We are dedicated to improve patient safety and determined to advance single-use devices. The manifestations of our efforts range from early inventions like the Ambu Bag™ resuscitator and the legendary BlueSensor™ electrodes to our newest landmark solutions like the aScope™ endoscope – the world's first single-use flexible video scope. Our commitment to bringing new ideas and superior service to our customers has made Ambu one of the most recognized medical companies in the world. Headquartered near Copenhagen in Denmark, Ambu employs approximately 2,500 people in Europe, North America and the Asia Pacific. For more information, please visit www.ambu.com.
Ambu
Company Announcement no. 7 2017/18
21 November 2017